Premium
Trans Fatty Acids and Coronary Heart Disease
Author(s) -
Zaloga Gary P.,
Harvey Kevin A.,
Stillwell William,
Siddiqui Rafat
Publication year - 2006
Publication title -
nutrition in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.725
H-Index - 71
eISSN - 1941-2452
pISSN - 0884-5336
DOI - 10.1177/0115426506021005505
Subject(s) - medicine , coronary heart disease , cholesterol , cardiology , sudden cardiac death , heart disease , lipoprotein , sudden death , disease , endocrinology
Epidemiologic evidence has linked trans fatty acids (TFAs) in the diet to coronary heart disease in human populations. It has been estimated that dietary TFAs from partially hydrogenated oils may be responsible for between 30,000 and 100,000 premature coronary deaths per year in the United States. Although it is known that TFAs increase low‐density lipoprotein (LDL) cholesterol levels and decrease high‐density lipoprotein (HDL) cholesterol levels (markers of coronary heart disease), there is little known about the mechanisms by which TFAs actually function at the cellular level. It is unknown what levels of TFAs are clinically significant and it is unclear how TFAs are associated with cardiac arrhythmias or sudden cardiac death. We hypothesize that TFAs affect membrane structure, thus altering enzymatic pathways that may subsequently induce cardiac arrhythmias and sudden death.